Samuel Rabkin

Deceased

from Boston, MA

Samuel Rabkin Phones & Addresses

  • Boston, MA

Us Patents

  • Use Of Soluble Costimulatory Factor For Tumor Immuno-Gene Therapy

    view source
  • US Patent:
    7064111, Jun 20, 2006
  • Filed:
    Oct 5, 2000
  • Appl. No.:
    09/679147
  • Inventors:
    Tomoki Todo - Belmont MA, US
    Samuel D. Rabkin - Lynn MA, US
    Robert L. Martuza - Cambridge MA, US
  • Assignee:
    Georgetown University - Washington DC
  • International Classification:
    A61K 48/00
    A61K 39/12
    A61K 39/245
    C12N 15/00
    C12N 5/00
  • US Classification:
    514 44, 4353201, 435325, 435455, 4241991, 4242311, 4241341
  • Abstract:
    A new gene therapy entails tumor treatment by introducing an expressible nucleotide sequence for a soluble costimulatory factor, thereby enhancing the response of T-cells to a tumor. In vivo expression of the soluble factor overcomes anergy or tolerance to tumor cells and activates T-cells that are infiltrating or surrounding the tumor. A pharmaceutical composition containing such a gene is effective in tumor suppression.
  • Viral Vectors And Their Use In Therapeutic Methods

    view source
  • US Patent:
    7749745, Jul 6, 2010
  • Filed:
    Mar 27, 2002
  • Appl. No.:
    10/107036
  • Inventors:
    Paul Johnson - Vancouver, CA
    Robert L. Martuza - Cambridge MA, US
    Samuel D. Rabkin - Lynn MA, US
    Tomoki Todo - Belmont MA, US
  • Assignee:
    Georgetown University - Washington DC
    The General Hospital Corporation - Boston MA
    MediGene, Inc. - San Diego CA
  • International Classification:
    C12N 7/00
    C12N 7/01
    A61K 39/245
  • US Classification:
    4352351, 4353201, 435440, 435455, 4242051, 4242311, 424 932, 424 936
  • Abstract:
    The invention provides viral vectors (e. g. , herpes viral vectors) and methods of using these vectors to treat disease.
  • Oncolytic Herpes Simplex Virus Immunotherapy In The Treatment Of Brain Cancer

    view source
  • US Patent:
    8313896, Nov 20, 2012
  • Filed:
    Apr 6, 2009
  • Appl. No.:
    12/384633
  • Inventors:
    Robert L. Martuza - Marblehead MA, US
    Samuel Rabkin - Swampscott MA, US
    William Curry - Boston MA, US
    Christopher Farrell - Brookline MA, US
    Cecile Zaupa - Bassoues, FR
  • Assignee:
    The General Hospital Corporation - Boston MA
  • International Classification:
    C12Q 1/70
  • US Classification:
    435 5
  • Abstract:
    Method of stimulating an immune response (e. g. , to treat cancer) include administering to a subject a composition including dendritic cells incubated with (i) oHSV-infected tumor cells or a composition derived therefrom, or (ii) tumor cells plus oHSV, as well as methods of preparing such compositions, are described.
  • Viral Vectors And Their Use In Therapeutic Methods

    view source
  • US Patent:
    8470577, Jun 25, 2013
  • Filed:
    Mar 11, 2010
  • Appl. No.:
    12/721599
  • Inventors:
    Paul Johnson - Vancouver, CA
    Robert L. Martuza - Cambridge MA, US
    Samuel D. Rabkin - Lynn MA, US
    Tomoki Todo - Belmont MA, US
  • Assignee:
    Catherex, Inc. - Dover DE
    The General Hospital Corporation - Boston MA
    Georgetown University - Washington DC
  • International Classification:
    C12N 7/00
    C12N 7/01
    A61K 39/245
  • US Classification:
    4352351, 4353201, 435440, 435456, 4242051, 4242311, 424 932, 424 936
  • Abstract:
    The invention provides viral vectors (e. g. , herpes viral vectors) and methods of using these vectors to treat disease.
  • Use On Oncolytic Herpes Viruses For Killing Cancer Stem Cells

    view source
  • US Patent:
    20110177032, Jul 21, 2011
  • Filed:
    May 4, 2009
  • Appl. No.:
    12/994960
  • Inventors:
    Robert Martuza - Marblehead MA, US
    Samuel Rabkin - Swampscott MA, US
    Hiroaki Wakimoto - Newton MA, US
    Ryuichi Kanai - Brookline MA, US
  • Assignee:
    The General Hospital Corporation d/b/a Massachusetts General Hospital - Boston MA
  • International Classification:
    A61K 35/76
    C12N 5/071
    A61P 35/00
    C12Q 1/70
  • US Classification:
    424 932, 435375, 435 5
  • Abstract:
    The invention, in some aspects, relates to the selective killing of cancer stem cells by oncolytic Herpes virus mediated oncolysis. In some aspects, the invention relates to methods for treating a subject having a cancer stem cell by administering to the subject an oncolytic Herpes virus. In other aspects, the invention provides methods for evaluating the efficacy of an oncolytic Herpes virus for killing cancer stem cells.

Youtube

WHOS IN YOUR ROOM?

10:30am Worship Service Bishop Samuel R. Blakes Message: WHO'S IN YOUR...

  • Duration:
    1h 32s

REFOCUSING YOUR MIND

7:00pm Tuesday Bible Study Bishop Samuel R. Blakes Message: REFOCUSING...

  • Duration:
    53m 3s

Abram Rabkin

I do love this artist,who paints the former shtetls and I dream of an ...

  • Duration:
    3m 53s

Samuel Ross gives business advice to young cr...

As part of the 2021 #OpenToChange initiative in partnership with Conve...

  • Duration:
    27m 43s

The Legend: Samuel Reshevsky - GM Ben Finegol...

Grandmaster Ben Finegold pays tribute to former U.S. Champion Sam Resh...

  • Duration:
    53m 54s

FCR 3: Samuel Ericsson vs Ruben Sibma

FCR 3: Samuel Ericsson vs Ruben Sibma #FCRMMA #KARATECOMBAT #SAMUELERI...

  • Duration:
    13m 25s

Googleplus

Samuel Rabkin Photo 1

Samuel Rabkin

Work:
Revolution Prep - Private Tutor
Education:
Cornell University

Get Report for Samuel Rabkin from Boston, MADeceased
Control profile